Mineralomics lab

Age-related problems such as kidney, heart and bone diseases are linked to impaired handling of tiny mineral particles containing calcium in our blood called calciprotein particles (CPP). Detecting and removing harmful CPP levels presents an opportunity to prevent or slow disease, improving patient outcomes and extending healthy lifespan.

The Mineralomics lab is situated at SKC-Central. This project pioneers the first-ever diagnostic testing targeting calciprotein particles (CPP) to predict and manage many diseases including ageing. The lab's cutting-edge approach could revolutionize how these conditions are detected and treated, offering preventive therapies and personalised care options for at-risk populations.

• Early prediction and prevention of chronic diseases
• Development of novel treatments to reduce CPP-related risks
• Reduced healthcare costs through evidence-based interventions
• Global recognition as a leader in CPP research, diagnostics & therapeutics

Patient Monitoring system

SKC has developed its own unique interface with our electronic medical record. This not only saves time but has huge advantages to keep all of the data in the electronic medical record for our software to analyse and present to our doctors for easy review of the dialysis sessions.